BDTX
Price
$1.90
Change
+$0.01 (+0.53%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
105.14M
38 days until earnings call
Intraday BUY SELL Signals
NGEN
Price
$1.78
Change
+$0.02 (+1.14%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
202.14M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs NGEN

BDTX vs NGEN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDTX vs. NGEN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and NGEN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BDTX vs NGEN: Fundamental Ratings
BDTX
NGEN
OUTLOOK RATING
1..100
6779
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
7781
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDTX's Valuation (56) in the null industry is in the same range as NGEN (60). This means that BDTX’s stock grew similarly to NGEN’s over the last 12 months.

BDTX's Profit vs Risk Rating (100) in the null industry is in the same range as NGEN (100). This means that BDTX’s stock grew similarly to NGEN’s over the last 12 months.

BDTX's SMR Rating (97) in the null industry is in the same range as NGEN (100). This means that BDTX’s stock grew similarly to NGEN’s over the last 12 months.

BDTX's Price Growth Rating (77) in the null industry is in the same range as NGEN (81). This means that BDTX’s stock grew similarly to NGEN’s over the last 12 months.

BDTX's P/E Growth Rating (99) in the null industry is in the same range as NGEN (100). This means that BDTX’s stock grew similarly to NGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDTXNGEN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
70%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (BDTX: $1.88 vs. NGEN: $1.76)
Brand notoriety: BDTX and NGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 53% vs. NGEN: 197%
Market capitalization -- BDTX: $105.14M vs. NGEN: $202.14M
BDTX [@Biotechnology] is valued at $105.14M. NGEN’s [@Biotechnology] market capitalization is $202.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green while NGEN’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • NGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BDTX and NGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 3 TA indicator(s) are bullish while NGEN’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 3 bullish, 7 bearish.
  • NGEN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NGEN is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а -0.53% price change this week, while NGEN (@Biotechnology) price change was -12.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

BDTX is expected to report earnings on Nov 09, 2026.

NGEN is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BDTX
Daily Signal:
Gain/Loss:
NGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BHK8.210.01
+0.12%
Blackrock Core BD TR
ENHU28.510.04
+0.12%
iShares Enhanced Large Cap Core Active ETF (ENHU)
VDC217.71-0.50
-0.23%
Vanguard Consumer Staples ETF (VDC)
FFGX33.69-0.19
-0.56%
Fidelity Fundamental Global ex-U.S. ETF
NEBX26.32-0.83
-3.06%
Tradr 2X Long NBIS Daily ETF (NEBX)

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with NGEN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then NGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-0.27%
NGEN - BDTX
46%
Loosely correlated
-7.85%
MLTX - BDTX
42%
Loosely correlated
-1.97%
REPL - BDTX
39%
Loosely correlated
+1.59%
CRBU - BDTX
35%
Loosely correlated
-3.94%
EDIT - BDTX
35%
Loosely correlated
-1.95%
More

NGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGEN has been loosely correlated with BDTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NGEN jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGEN
1D Price
Change %
NGEN100%
-7.85%
BDTX - NGEN
45%
Loosely correlated
-0.27%
MIST - NGEN
27%
Poorly correlated
-5.78%
ABEO - NGEN
26%
Poorly correlated
-4.57%
PHVS - NGEN
25%
Poorly correlated
-2.24%
NXTC - NGEN
24%
Poorly correlated
-1.00%
More